文献速递慢性肾脏病

医疗数据库中慢性肾脏病(CKD)患者识别:不同算法的比较

Identification of Patients with CKD in Medical Databases: A Comparison of Different Algorithms.
PubMed 文献 · Clin J Am Soc Nephrol · 2021-03-11

在丹麦北部2009-2016年人群中,应用六种算法(五种基于实验室指标,一种基于医院诊断)识别CKD患者。五种实验室算法估计的CKD患病率差异大(4637-8327/10万),但1年死亡率相近(7%-9%);医院诊断算法患病率低(775/10万),但1年死亡率高(22%)。

要点

  • 不同实验室算法导致CKD患病率估计差异显著,但队列预后相似。
  • 医院诊断算法识别的CKD患者合并症更多,1年死亡率更高。
  • 选择CKD算法时需权衡患病率估计与患者特征。

核心结论

  • 医疗数据库中CKD的患病率估计高度依赖于所采用的算法。
  • 基于实验室指标的算法产生预后相似的队列,而医院诊断算法识别的人群预后更差。

研究设计与样本

  • 基于人群的医疗数据库研究,纳入丹麦北部2009-2016年CKD患者。
  • 应用六种算法:五种基于实验室指标,一种基于医院诊断。

主要发现

  • 五种实验室算法估计的CKD患病率为4637-8327/10万,1年死亡率7%-9%。
  • 医院诊断算法估计的CKD患病率为775/10万,1年死亡率22%。
  • 基线eGFR在实验室算法间相似(53-56 ml/min per 1.73 m2),医院诊断算法较低(47 ml/min per 1.73 m2)。

关键数值与推荐

  • 单次eGFR<60 ml/min per 1.73 m2(n=103,435)。
  • 两次eGFR<60间隔≥90天(KDIGO,n=84,688)。
  • 两次eGFR<60间隔≥90天且期间无eGFR>60(KDIGO持续,n=68,994)。
  • 两次eGFR<60间隔≥90天且<365天(KDIGO限时,n=75,031)。
  • 两次eGFR<60或两次UACR>30 mg/g间隔≥90天(KDIGO eGFR/白蛋白尿,n=100,957)。

临床怎么用

  • 临床研究中选择CKD算法需考虑对患病率估计的影响。
  • 医院诊断算法识别的人群死亡风险更高,可能反映更严重或更晚期的CKD。

局限性

  • 研究仅基于丹麦北部人群,外推性可能有限。
  • 未报告算法间的具体比较统计检验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Despite CKD consensus definitions, epidemiologic studies use multiple different algorithms to identify CKD. We aimed to elucidate if this affects the patient characteristics and the estimated prevalence and prognosis of CKD by applying six different algorithms to identify CKD in population-based medical databases and compare the cohorts. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Patients with CKD in Northern Denmark (2009-2016) were identified using six different algorithms: five were laboratory based defined by (1) one measured outpatient eGFR <60 ml/min per 1.73 m2 (single test, n=103,435), (2) two such findings ≥90 days apart (Kidney Disease Improving Global Outcomes, n=84,688), (3) two such findings ≥90 days apart with no eGFR >60 ml/min per 1.73 m2 observed in-between (Kidney Disease Improving Global Outcomes, persistent, n=68,994), (4) two such findings ≥90 and <365 days apart (Kidney Disease Improving Global Outcomes, time limited, n=75,031), and (5) two eGFRs <60 ml/min per 1.73 m2 or two urine albumin-creatinine ratios >30 mg/g ≥90 days apart (Kidney Disease Improving Global Outcomes, eGFR/albuminuria, n=100,957). The sixth included patients identified by reported in- and outpatient hospital International Classification of Diseases diagnoses of CKD (hospital-diagnosed, n=27,947). For each cohort, we estimated baseline eGFR, CKD prevalence, and 1-year mortality using the Kaplan-Meier method. RESULTS: The five different laboratory-based algorithms resulted in large differences in the estimated prevalence of CKD from 4637-8327 per 100,000 population. In contrast, 1-year mortality varied only slightly (7%-9%). Baseline eGFR levels at diagnosis were comparable (53-56 ml/min per 1.73 m2), whereas median time since first recorded eGFR <60 ml/min per 1.73 m2 varied from 0 months (single-test) to 17 months (Kidney Disease Improving Global Outcomes, persistent). The hospital-diagnosed algorithm yielded markedly lower CKD prevalence (775 per 100,000 population), a lower baseline eGFR (47 ml/min per 1.73 m2), longer time since first eGFR <60 ml/min per 1.73 m2 (median 70 months), and much higher 1-year mortality (22%). CONCLUSIONS: Population prevalence of CKD identified in medical databases greatly depends on the applied algorithm to define CKD. Despite these differences, laboratory-based algorithms produce cohorts with similar prognosis. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2021_03_11_CJN15691020_final.mp3.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Vestergaard SV, Christiansen CF, Thomsen RW, et al. Identification of Patients with CKD in Medical Databases: A Comparison of Different Algorithms. Clin J Am Soc Nephrol. 2021. PMID: 33707181. doi:10.2215/CJN.15691020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。